Cellectar Biosciences Stock Price History

CLRB Stock  USD 5.23  0.24  4.81%   
Below is the normalized historical share price chart for Cellectar Biosciences extending back to June 14, 2005. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Cellectar Biosciences stands at 5.23, as last reported on the 21st of July, with the highest price reaching 5.45 and the lowest price hitting 4.99 during the day.
IPO Date
10th of November 2005
200 Day MA
20.8597
50 Day MA
7.9108
Beta
0.521
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
If you're considering investing in Cellectar Stock, it is important to understand the factors that can impact its price. Cellectar Biosciences secures Sharpe Ratio (or Efficiency) of -0.0278, which signifies that the company had a -0.0278 % return per unit of risk over the last 3 months. Cellectar Biosciences exposes twenty-two different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Cellectar Biosciences' Standard Deviation of 11.09, risk adjusted performance of (0.02), and Mean Deviation of 6.05 to double-check the risk estimate we provide.
At present, Cellectar Biosciences' Common Stock Shares Outstanding is projected to increase significantly based on the last few years of reporting. The current year's Other Stockholder Equity is expected to grow to about 274.2 M, whereas Total Stockholder Equity is forecasted to decline to about 8.9 M. . The current year's Price To Sales Ratio is expected to grow to -1,046. In addition to that, Price Earnings Ratio is expected to decline to -0.26. Cellectar Stock price history is provided at the adjusted basis, taking into account all of the recent filings.

Sharpe Ratio = -0.0278

Best PortfolioBest Equity
Good Returns
Average Returns
Small Returns
CashSmall RiskAverage RiskHigh RiskHuge Risk
Negative ReturnsCLRB

Estimated Market Risk

 11.32
  actual daily
96
96% of assets are less volatile

Expected Return

 -0.31
  actual daily
0
Most of other assets have higher returns

Risk-Adjusted Return

 -0.03
  actual daily
0
Most of other assets perform better
Based on monthly moving average Cellectar Biosciences is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Cellectar Biosciences by adding Cellectar Biosciences to a well-diversified portfolio.
Price Book
1.8437
Book Value
5.034
Enterprise Value
1.3 M
Enterprise Value Ebitda
(3.25)
Shares Float
1.5 M

Cellectar Biosciences Stock Price History Chart

There are several ways to analyze Cellectar Stock price data. The simplest method is using a basic Cellectar candlestick price chart, which shows Cellectar Biosciences price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
Highest PriceJune 4, 202513.85
Lowest PriceJuly 8, 20254.7

Cellectar Biosciences July 21, 2025 Stock Price Synopsis

Various analyses of Cellectar Biosciences' daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell Cellectar Stock. It can be used to describe the percentage change in the price of Cellectar Biosciences from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of Cellectar Stock.
Cellectar Biosciences Price Rate Of Daily Change 1.05 
Cellectar Biosciences Accumulation Distribution 11,077 
Cellectar Biosciences Price Action Indicator 0.13 
Cellectar Biosciences Price Daily Balance Of Power 0.52 

Cellectar Biosciences July 21, 2025 Stock Price Analysis

When benchmark price declines in a down market, there may be an uptick in Cellectar Stock price where buyers come in believing the asset is cheap or selling overdone. The opposite is true when the market is bullish. You can use Cellectar Biosciences intraday prices and daily technical indicators to check the level of noise trading in Cellectar Stock and then apply it to test your longer-term investment strategies against Cellectar.

Cellectar Stock Price History Data

The price series of Cellectar Biosciences for the period between Tue, Apr 22, 2025 and Mon, Jul 21, 2025 has a statistical range of 9.15 with a coefficient of variation of 27.53. The prices are distributed with arithmetic mean of 8.07. The median price for the last 90 days is 7.92. The company had 1:30 stock split on 24th of June 2025. Cellectar Biosciences issued dividends on 2018-07-17.
OpenHighLowCloseVolume
07/21/2025
 4.99  5.45  4.99  5.23  131,236 
07/21/2025
 4.99  5.45  4.99  5.23  131,236 
07/18/2025 4.98  5.07  4.89  4.99  54,242 
07/17/2025
 5.04  5.33  4.97  4.97  114,383 
07/16/2025
 4.90  5.30  4.88  5.04  156,666 
07/15/2025
 4.91  4.95  4.74  4.78  71,636 
07/14/2025
 4.95  5.02  4.81  4.98  53,505 
07/11/2025
 4.96  5.05  4.80  4.88  61,394 
07/10/2025
 4.80  5.05  4.74  4.93  53,554 
07/09/2025
 4.70  4.99  4.70  4.85  118,917 
07/08/2025
 4.62  4.86  4.62  4.70  118,265 
07/07/2025
 4.68  4.91  4.65  4.80  135,085 
07/03/2025
 5.17  5.17  4.61  4.80  238,953 
07/02/2025
 4.86  5.07  4.60  4.73  211,057 
07/01/2025 5.28  5.40  4.36  4.86  860,924 
06/30/2025
 8.02  8.05  7.11  7.11  129,444 
06/27/2025
 7.03  8.30  7.03  7.90  118,577 
06/26/2025 7.75  8.19  6.50  7.38  331,206 
06/25/2025
 9.31  10.19  7.60  7.94  276,184 
06/24/2025 8.55  9.85  8.30  9.70  179,613 
06/23/2025 9.00  9.25  8.41  8.93  76,541 
06/20/2025
 9.99  10.80  8.70  8.75  128,103 
06/18/2025 10.35  12.00  10.35  10.97  72,708 
06/17/2025
 11.40  11.93  10.37  10.54  80,524 
06/16/2025
 11.65  12.13  11.29  11.47  65,570 
06/13/2025
 12.60  13.47  12.15  12.40  94,763 
06/12/2025
 12.60  13.95  12.30  13.11  193,607 
06/11/2025 12.00  13.20  11.45  12.80  492,681 
06/10/2025
 10.80  11.70  10.53  10.98  162,166 
06/09/2025
 10.50  11.40  9.65  10.65  232,059 
06/06/2025
 11.70  12.09  10.29  10.82  299,261 
06/05/2025
 13.16  13.72  10.67  12.24  1,333,646 
06/04/2025
 12.77  20.60  11.70  13.85  20,870,200 
06/03/2025
 8.10  8.76  7.84  8.33  38,178 
06/02/2025
 7.68  7.96  7.65  7.86  23,519 
05/30/2025
 7.95  7.95  7.44  7.65  7,129 
05/29/2025
 7.37  8.01  7.34  7.92  37,629 
05/28/2025
 7.65  7.65  7.23  7.37  23,318 
05/27/2025
 7.53  7.63  7.25  7.59  38,015 
05/23/2025
 7.53  7.75  7.26  7.47  11,600 
05/22/2025 7.50  7.62  7.20  7.56  12,177 
05/21/2025
 8.22  8.22  7.30  7.47  19,101 
05/20/2025
 7.62  8.00  7.53  7.92  35,151 
05/19/2025
 7.28  7.78  7.28  7.67  20,358 
05/16/2025
 7.47  7.73  7.25  7.35  20,528 
05/15/2025
 7.23  7.67  7.21  7.61  24,551 
05/14/2025
 7.32  7.32  6.90  7.22  40,163 
05/13/2025
 8.03  8.10  7.20  7.20  47,738 
05/12/2025
 7.88  7.92  7.43  7.92  15,145 
05/09/2025
 7.49  7.73  7.36  7.42  9,614 
05/08/2025
 7.50  7.86  7.33  7.55  17,671 
05/07/2025
 7.20  7.40  7.05  7.33  14,095 
05/06/2025
 7.71  7.92  7.20  7.22  33,379 
05/05/2025
 8.22  8.37  7.70  7.98  24,899 
05/02/2025
 8.07  8.22  7.50  8.12  40,624 
05/01/2025
 7.74  8.03  7.61  7.93  12,033 
04/30/2025
 8.40  8.40  7.20  7.55  68,302 
04/29/2025
 8.93  9.02  8.43  8.73  37,553 
04/28/2025
 9.02  9.23  8.73  8.89  24,560 
04/25/2025
 9.51  9.60  9.05  9.30  13,234 
04/24/2025
 9.34  9.42  8.92  9.39  11,625 

About Cellectar Biosciences Stock history

Cellectar Biosciences investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Cellectar is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Cellectar Biosciences will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Cellectar Biosciences stock prices may prove useful in developing a viable investing in Cellectar Biosciences
Last ReportedProjected for Next Year
Common Stock Shares Outstanding37.1 M39 M
Net Loss-25.7 M-24.5 M

Cellectar Biosciences Stock Technical Analysis

Cellectar Biosciences technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of Cellectar Biosciences technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Cellectar Biosciences trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Did you try this?

Run Portfolio Center Now

   

Portfolio Center

All portfolio management and optimization tools to improve performance of your portfolios
All  Next Launch Module

Cellectar Biosciences Technical and Predictive Indicators

Predictive indicators are helping investors to find signals for Cellectar Biosciences' price direction in advance. Along with the technical and fundamental analysis of Cellectar Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Cellectar to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.

Complementary Tools for Cellectar Stock analysis

When running Cellectar Biosciences' price analysis, check to measure Cellectar Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cellectar Biosciences is operating at the current time. Most of Cellectar Biosciences' value examination focuses on studying past and present price action to predict the probability of Cellectar Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cellectar Biosciences' price. Additionally, you may evaluate how the addition of Cellectar Biosciences to your portfolios can decrease your overall portfolio volatility.
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
FinTech Suite
Use AI to screen and filter profitable investment opportunities
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments